Brief: Coloplast - Outlook FY FY 2024/25 Guidance On Organic Growth Of 8-9% And On EBIT Margin Before Special Items Of Around 28% Unchanged
04/02/2025 06:32
Coloplast A/S COLOb.CO :
* COLOPLAST - OUTLOOK FY: FY 2024/25 GUIDANCE ON ORGANIC
GROWTH OF
8-9% AND ON EBIT MARGIN BEFORE SPECIAL ITEMS OF AROUND 28%
UNCHANGED
* COLOPLAST - GROSS MARGIN WAS POSITIVELY IMPACTED BY A
FAVOURABLE
DEVELOPMENT IN INPUT COSTS, PRICE INCREASES, AND COUNTRY AND
PRODUCT MIX
Source text: ID:nGNE3ckjdG
Further company coverage: COLOb.CO
Recent news on Coloplast A/S
See all newsMorgan Stanley sees selective medtech opportunities on growth recovery
Brief: Coloplast’s Inflatable Penile Prosthesis Approved By FDA
Denmark's Coloplast Q2 organic revenue rises 6% on urology momentum
Brief: Coloplast Books DKK 3 Bln Impairment In H1
Brief: Coloplast Receives Innovative Technology Contract From Vizient For Biatain® Silicone Fit